OrthoPediatrics Statistics
Total Valuation
OrthoPediatrics has a market cap or net worth of $419.69 million. The enterprise value is $468.70 million.
Important Dates
The last earnings date was Thursday, April 30, 2026, after market close.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OrthoPediatrics has 25.68 million shares outstanding. The number of shares has increased by 1.69% in one year.
| Current Share Class | 25.68M |
| Shares Outstanding | 25.68M |
| Shares Change (YoY) | +1.69% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 5.77% |
| Owned by Institutions (%) | 60.69% |
| Float | 15.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.67 |
| Forward PS | 1.47 |
| PB Ratio | 1.19 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.33.
| Current Ratio | 5.21 |
| Quick Ratio | 2.19 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1,320.00 |
| Debt / FCF | n/a |
| Interest Coverage | -3.79 |
Financial Efficiency
Return on equity (ROE) is -11.57% and return on invested capital (ROIC) is -3.76%.
| Return on Equity (ROE) | -11.57% |
| Return on Assets (ROA) | -3.39% |
| Return on Invested Capital (ROIC) | -3.76% |
| Return on Capital Employed (ROCE) | -5.80% |
| Weighted Average Cost of Capital (WACC) | 8.65% |
| Revenue Per Employee | $404,151 |
| Profits Per Employee | -$65,907 |
| Employee Count | 602 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 0.52 |
Taxes
In the past 12 months, OrthoPediatrics has paid $93,000 in taxes.
| Income Tax | 93,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.05% in the last 52 weeks. The beta is 0.99, so OrthoPediatrics's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -25.05% |
| 50-Day Moving Average | 16.69 |
| 200-Day Moving Average | 18.03 |
| Relative Strength Index (RSI) | 49.05 |
| Average Volume (20 Days) | 179,116 |
Short Selling Information
The latest short interest is 944,283, so 3.68% of the outstanding shares have been sold short.
| Short Interest | 944,283 |
| Short Previous Month | 965,855 |
| Short % of Shares Out | 3.68% |
| Short % of Float | 5.94% |
| Short Ratio (days to cover) | 5.55 |
Income Statement
In the last 12 months, OrthoPediatrics had revenue of $243.30 million and -$39.68 million in losses. Loss per share was -$1.68.
| Revenue | 243.30M |
| Gross Profit | 177.79M |
| Operating Income | -26.39M |
| Pretax Income | -39.58M |
| Net Income | -39.68M |
| EBITDA | -4.60M |
| EBIT | -26.39M |
| Loss Per Share | -$1.68 |
Full Income StatementBalance Sheet
The company has $48.81 million in cash and $112.20 million in debt, with a net cash position of -$63.39 million or -$2.47 per share.
| Cash & Cash Equivalents | 48.81M |
| Total Debt | 112.20M |
| Net Cash | -63.39M |
| Net Cash Per Share | -$2.47 |
| Equity (Book Value) | 338.71M |
| Book Value Per Share | 13.23 |
| Working Capital | 198.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.98 million and capital expenditures -$8.64 million, giving a free cash flow of -$12.63 million.
| Operating Cash Flow | -3.98M |
| Capital Expenditures | -8.64M |
| Depreciation & Amortization | 21.79M |
| Net Borrowing | 23.49M |
| Free Cash Flow | -12.63M |
| FCF Per Share | -$0.49 |
Full Cash Flow StatementMargins
Gross margin is 73.07%, with operating and profit margins of -10.85% and -16.31%.
| Gross Margin | 73.07% |
| Operating Margin | -10.85% |
| Pretax Margin | -16.27% |
| Profit Margin | -16.31% |
| EBITDA Margin | -1.89% |
| EBIT Margin | -10.85% |
| FCF Margin | n/a |
Dividends & Yields
OrthoPediatrics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.69% |
| Shareholder Yield | -1.69% |
| Earnings Yield | -9.79% |
| FCF Yield | -3.11% |
Analyst Forecast
The average price target for OrthoPediatrics is $24.67, which is 50.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.67 |
| Price Target Difference | 50.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OrthoPediatrics has an Altman Z-Score of 1.76 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.76 |
| Piotroski F-Score | 3 |
